France · Investor

Auriga Partners

Filed with the SEC to raise a fund in Oct 2026, closing $89M. Last cheque observed Jul 2015.

QuietNew fund $89M, Oct 2026VC firm

Series BSeries ASeries CMedia And EntertainmentInvestment Management

Cheques on record
0%of best year0cheques in 12 months, 146 on record
Since the last cheque4127days00hrs00min00sec
Median round$7.6MRounds led0 of 146Sole investor49 roundsExits7 from the portfolioMostly inFrance, 69%
Pitch Auriga Partners

Auriga Partners highlights

  1. 01

    146 rounds on record

  2. 02

    Mostly Series B and Series A: 55% of its rounds

  3. 03

    Sole investor in 49 rounds, median $3.6M

  4. 04

    7 exits from the portfolio

What they do

Auriga Partners, une société de gestion de capital-risque pionnière en France depuis 1998From their own website
Type
VC firm
Cheque size
Not stated
Sectors
Media And EntertainmentInvestment Management
Based in
Paris, France
Cold pitches
Not stated

The record

Every round we can evidence, newest first146 appearances

  1. 2015

    2 rounds

  2. Jul
    aveniVenture · FR$14MWith 4 others
  3. Jan
    CoLucid PharmaceuticalsSeries C · US$37MWith 7 others
  4. 2014

    13 rounds

  5. Dec
    NexthinkSeries D · CH$15MWith 3 others
  6. Dec
    Pherecydes PharmaSeries A · FR$2.4MSole investor
  7. Nov
    TheranexusSeed · PT$4.5MWith 1 other
  8. Jul
    AmoebaSeries A · FR$889KSole investor
  9. Jun
    NexthinkVenture · CH$7.0MSole investor
  10. Jun
    WallixVenture · FR$1.5MSole investor
  11. May
    Fab'entechSeries A · FR$4.1MSole investor
  12. May
    ConvertigoVenture · FR$1.5MSole investor
  13. Apr
    eXoVenture · US$1.2MSole investor
  14. Apr
    TxCellVenture · FR$21MSole investor
  15. Apr
    SuperSonic ImagineGrowth · FR$21MSole investor
  16. Apr
    aveniSeries F · FR$1.5MSole investor
  17. Mar
    StantumVenture · FR$626KSole investor
  18. 2013

    12 rounds

  19. Dec
    Median TechnologiesSeries F · FR$680KSole investor
  20. Nov
    ImplanetSeries E · FR$25MSole investor
  21. Oct
    Genocea BiosciencesSeries E · US · sec.gov$400KSole investor
  22. Jul
    FiralisSeries B · FR$1.9MWith 1 other
  23. Jun
    MilibooSeries B · FR$5.2MWith 2 others
  24. May
    BonitaSoftSeries C · FR · techcrunch.com$13MWith 4 others
  25. May
    aveniSeries E · FR$4.5MSole investor
  26. Apr
    SuperSonic ImagineGrowth · FR · pevc.dowjones.com$36MWith 8 others
  27. Apr
    EkinopsSeries E · FR$8.6MSole investor
  28. Apr
    ERYtech PharmaSeries D · FR$19MSole investor
  29. Mar
    Population Genetics TechnologiesSeries G · GB$471KSole investor
  30. Feb
    CodenvySeries A · US · techcrunch.com$9.0MWith 1 other
  31. 2012

    10 rounds

  32. Nov
    TxCellSeries C · FR · finsmes.com$16MWith 2 others
  33. Oct
    Genocea BiosciencesSeries C · US · masshightech.com$30MWith 9 others
  34. Sept
    Population Genetics TechnologiesSeries F · GB$1.6MSole investor
  35. Jul
    DOMAIN TherapeuticsVenture · FR · finsmes.com$2.5MWith 3 others
  36. Jun
    WallixSeries E · FR$2.5MWith 2 others
  37. Apr
    EpticaSeries C · FR$9.2MWith 1 other
  38. Mar
    NexthinkSeries C · CH · finsmes.com$5.5MWith 1 other
  39. Jan
    AmplitudeSeries B · FR$39MWith 3 others
  40. Jan
    NeolaneVenture · FR · neolane.com$27MWith 2 others
  41. Jan
    IDbyMESeries B$4.5MWith 2 others
  42. 2011

    11 rounds

  43. Nov
    CytooSeries C · FR · cytoo.com$10MWith 2 others
  44. Nov
    WallixSeries D · FR$2.7MSole investor
  45. Oct
    Population Genetics TechnologiesSeries B · GB · fis.dowjones.com$5.7MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 6 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who backs their funds

2 LPs on record in Auriga Partners's funds

Funds
1

The institutions that put money into its funds, which the firm then invests in companies.Source: fund news.

Exits from the portfolio

Companies it backed that were later bought or listed7 in all

CodenvyBought by RedhatUndisclosedMay 2017
NeolaneBought by Adobe Systems$600MJun 2013
Streamcore SystemBought by ORSYPUndisclosedNov 2012
Open-PlugBought by Alcatel-LucentUndisclosedSept 2010
BiolipoxBought by OrexoUndisclosedNov 2007
Spine NextBought by Abbott LabsUndisclosedOct 2004

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Auriga Partners. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Auriga Partners

What does Auriga Partners invest in?

Auriga Partners invests most often at Series B and Series A (55% of the rounds on record), in sectors such as Media And Entertainment and Investment Management.

How active is Auriga Partners?

146 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2015.

How big are Auriga Partners's cheques?

The median round it joins is $7.6M.

Does Auriga Partners lead rounds?

Rarely, if at all: none of its 146 investments on record names it as the lead.

Where does Auriga Partners invest?

Most of the companies it backs are in France (69%), the United States (13%) and Switzerland (8%).

Is Auriga Partners investing now?

No investments in the last 12 months; the latest was in Jul 2015.

Who does Auriga Partners invest alongside?

Most often Groupe Siparex (13 rounds together), Edmond de Rothschild Venture Capital (12 rounds together) and Omnes (11 rounds together).

What kind of investor is Auriga Partners?

Auriga Partners is a VC firm based in Paris, France.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it